Princeton Capital Management’s Biogen BIIB Stock Holding History

Princeton Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,071	Closed	-$1.27M	–	81
2016 Q3	$1.27M	Sell	4,071 -1,451	-26%	-$430K	1.57%	21
2016 Q2	$1.33M	Buy	5,522 +625	+13%	+$165K	1.53%	31
2016 Q1	$1.27M	Buy	4,897 +221	+5%	+$58.4K	1.44%	42
2015 Q4	$1.43M	Buy	4,676 +296	+7%	+$85.1K	1.61%	21
2015 Q3	$1.28M	Buy	4,380 +433	+11%	+$143K	1.45%	32
2015 Q2	$1.59M	Sell	3,947 -250	-6%	-$100K	1.61%	11
2015 Q1	$1.77M	Sell	4,197 -3	-0.1%	-$1.18K	1.73%	8
2014 Q4	$1.43M	Buy	+4,200	New	+$1.36M	1.41%	39

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Princeton Capital Management's BIIB Position: Q4 2016 in Review

Princeton Capital Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 4,071 shares — an estimated $1.27M sold.

Princeton Capital Management first reported a position in BIIB in Q4 2014 and held it in 8 quarters. The position peaked at $1.77M in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Princeton Capital Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Princeton Capital Management sold 4,071 Biogen shares in Q4 2016, an estimated $1.27M.
Princeton Capital Management first reported a position in Biogen in Q4 2014 and held it in 8 quarters.
Princeton Capital Management's Biogen position peaked at $1.77M in Q1 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Princeton Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.